Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular vesicles from fermented foods: sources, characteristics, functionalities, and future applications.

Food chemistry·2026
Same author

Liquorice alters adipocyte-breast cancer cell crosstalk by modulating oxidative stress and suppressing aromatase and renin-angiotensin signalling.

International journal of food sciences and nutrition·2026
Same author

Adjuvant treatment with an oleuropein-enriched olive leaf extract improves periodontal outcomes in older adults with periodontitis: Metabolomic insights from a randomized controlled trial.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Correction to: The effect of anthocyanins and anthocyanin‑rich foods on cognitive function: a meta‑analysis of randomized controlled trials.

GeroScience·2026
Same author

The Health Benefits of <i>Tamarindus indica</i>: A Focus on the Relationship Between Phytochemical Composition and Physiological Effects.

Nutrients·2026
Same author

The effect of anthocyanins and anthocyanin-rich foods on cognitive function: a meta-analysis of randomized controlled trials.

GeroScience·2025

Related Experiment Video

Updated: May 15, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Curcumin and liver disease.

Laura Vera-Ramirez1, Patricia Pérez-Lopez, Alfonso Varela-Lopez

  • 1GENyO Center Pfizer-University of Granada & Andalusian Government Centre for Genomics & Oncology, Granada, Spain.

Biofactors (Oxford, England)
|January 11, 2013
PubMed
Summary

Curcumin, a compound found in turmeric, shows promise in managing liver diseases by reducing fat accumulation and providing antioxidant protection. Its effects on cellular redox balance and mitochondria are key to its hepatoprotective benefits.

More Related Videos

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
10:15

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin

Published on: November 1, 2019

Related Experiment Videos

Last Updated: May 15, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
10:15

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin

Published on: November 1, 2019

Area of Science:

  • Biochemistry
  • Hepatology
  • Pharmacology

Background:

  • Liver diseases represent a significant global health challenge.
  • Herbal remedies are increasingly investigated for liver disease management.
  • Curcumin, derived from turmeric, has a long history in traditional medicine and growing scientific interest.

Purpose of the Study:

  • To explore the hepatoprotective mechanisms of curcumin.
  • To investigate curcumin's role in preventing fatty acid accumulation in hepatocytes.
  • To understand curcumin's antioxidant and anti-inflammatory effects in liver health.

Main Methods:

  • Review of existing research on curcumin's effects on liver function.
  • Analysis of curcumin's impact on cellular pathways, including NF-κβ signaling.
  • Examination of curcumin's influence on mitochondrial function and cellular redox balance.

Main Results:

  • Curcumin demonstrates a hypolipidic effect, preventing fatty acid buildup in hepatocytes and mitigating nonalcoholic steatohepatitis.
  • Curcumin exhibits potent antioxidant activity, crucial for combating chronic liver diseases, carcinogenesis, and age-related conditions.
  • Curcumin's interaction with NF-κβ (nuclear factor kappa-light-chain-enhancer of activated B cells) is central to its liver-protective role.

Conclusions:

  • Curcumin offers significant hepatoprotective benefits through its hypolipidic and antioxidant properties.
  • Its modulation of cellular redox balance and mitochondrial activity underpins its therapeutic potential for liver diseases.
  • Further research into curcumin's molecular mechanisms can advance its clinical application in liver health.